Zobrazeno 1 - 10
of 17
pro vyhledávání: '"James Shao"'
Autor:
Yang, James Shao-Jiun, Fang, Lei
Publikováno v:
In Chem 13 June 2024 10(6):1668-1724
Autor:
Randall A. Ow, Steven Shotts, Venkata Kakarlapudi, John McIntyre, Robert M. Naclerio, Changcheng You, Alexander Pappas, Lindsay Brayton, Yina Kuang, James Shao
Publikováno v:
American Journal of Rhinology & Allergy. 36:733-740
Background The efficacy of topical corticosteroids is limited in chronic rhinosinusitis (CRS) due to rapid clearance from the nasal cavity and insufficient drug delivery to inflamed sinonasal passages. LYR-210 is an implantable corticosteroid matrix
Autor:
Joanne Rimmer, Anders Cervin, Agnieszka Wrobel, Allison Gartung, Lindsay Brayton, James Shao, Vineeta Belanger
Publikováno v:
International Forum of Allergy & Rhinology.
Autor:
Gozde Colak, Vikas Gupta, Andrea Patriarca, John Mascarenhas, Patricia J. Keller, James Shao, Claire N. Harrison, Nikki Granacher, Gary J. Schiller, Tim C. P. Somervaille, Moshe Talpaz, Jonathan Lambert, Katarina Luptakova, Srdan Verstovsek, Raajit Rampai, Ronald Hoffman, Linda Foltz, Prithviraj Bose, Marina Kremyanskaya, Alessandro M. Vannucchi, Witold Prejzner, Mark Drummond
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S361-S362
Context: Pelabresib (CPI-0610), a first-in-class, oral, small-molecule inhibitor of BET proteins, has the potential to promote disease-modifying activity through altered gene regulation of key oncogenic, fibrotic, and inflammatory factors in MF. Many
Autor:
Vikas Gupta, Marina Kremyanskaya, John Mascarenhas, Francesca Palandri, Andrea Patriarca, Timothy Devos, Claire Harrison, Francesco Passamonti, Raajit Rampal, Adam Mead, Joseph Scandura, Gabriela Hobbs, Moshe Talpaz, Nikki Granacher, Tim Somervaille, Ronald Hoffman, Prithviraj Bose, Gozde Colak, James Shao, Jike Cui, Suresh Bobba, Katarina Luptakova, Srdan Verstovsek
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S234
Autor:
Jike Cui, Joseph M. Scandura, James Shao, Andrea Patriarca, Gozde Colak, Prithviraj Bose, Marina Kremyanskaya, Nikki Granacher, Francesco Passamonti, Moshe Talpaz, Srdan Verstovsek, John Mascarenhas, Raajit K. Rampal, Gabriela S. Hobbs, Timothy Devos, Suresh Bobba, Francesca Palandri, Claire N. Harrison, Tim C. P. Somervaille, Vikas Gupta, Adam J. Mead, Katarina Luptakova, Ronald Hoffman
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S362
Context: Pelabresib (CPI-0610), a first-in-class, oral, small-molecule inhibitor of BET proteins (BETi), has potential to promote disease-modifying activity through altered gene regulation of key oncogenic, fibrotic, and inflammatory factors in MF. T
Autor:
Gozde Colak, Patrick Trojer, Srdan Verstovsek, Jeffrey S. Humphrey, John Mascarenhas, Jing Wang, Katarina Luptakova, Suresh Bobba, Claire N. Harrison, James Shao
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S363
Context: CPI-0610 is a unique, first-in-class, oral, small-molecule inhibitor of BET proteins, designed to promote disease-modifying activity through selective gene regulation of key oncogenic, fibrotic, and inflammatory factors with potential to tra
Autor:
Prithviraj Bose, Srdan Verstovsek, Marina Kremyanskaya, John Mascarenhas, Moshe Talpaz, Claire Harrison, Raajit Rampal, Andrea Patriarca, Vikas Gupta, Nikki Granacher, Tim Somervaille, Gary Schiller, Mark Drummond, Linda Foltz, Jonathan Lambert, Witold Prejzner, Gozde Colak, Patricia Keller, James Shao, Katarina Luptakova, Ronald Hoffman, Alessandro Vannucchi
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S234
Autor:
John Mascarenhas, Claire Harrison, Katarina Luptakova, Jing Wang, Gozde Colak, James Shao, Suresh Bobba, Patrick Trojer, Jeffrey Humphrey, Srdan Verstovsek
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S235
Autor:
Gozde Colak, Patricia J. Keller, Srdan Verstovsek, Jing Wang, John Mascarenhas, Jike Cui, Adam J. Mead, Rosana D Meyer, Jennifer A. Mertz, Katarina Luptakova, Oksana Zavidij, Ruben A. Mesa, Patrick Trojer, Jeffrey S. Humphrey, Mohamed E. Salama, Jean-Jacques Kiladjian, Vikas Gupta, James Shao, Claire N. Harrison, Adrian M. Senderowicz, Moshe Talpaz
Publikováno v:
Blood. 136:37-38
Myelofibrosis (MF) is characterized by progressive bone marrow (BM) fibrosis resulting from aberrant megakaryopoeisis and expression of pro-inflammatory cytokines. These two processes, heavily influenced by bromodomain and extraterminal domain (BET)-